At this time, posts about Wooridul Pharmaceutical are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 11,000 shares today. Wooridul Pharmaceutical is known as a manufacturer and seller of pharmaceuticals focused on therapeutics.

As of 12:30 PM on the 12th, Wooridul Pharmaceutical's stock price remains unchanged from the previous day at 13,400 KRW, with a trading volume of 2,778,347 shares, which is 50.82% of the 5-day average trading volume. On August 4th, Wooridul Pharmaceutical became a market issue with a sharp rise due to expectations for the "COVID-19 antibody rapid diagnostic kit."

In addition to Wooridul Pharmaceutical, posts from investors are also surging regarding Access Bio (950130), Samsung C&T (028260), and Doosan Heavy Industries & Construction (034020).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing